Join NFCR and Dr. Sujuan Ba in Discussion about All Things Cancer
Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it.
Subscribe now to stay up to date on the latest episodes and join the conversation shaping the future of cancer research.
LISTEN NOW:
Latest Episodes of All Things Cancer

Episode #15:
We’re Drowning in Cancer Data — And Still Missing Cures with Dr. Anna Barker
In the latest episode of All Things Cancer, Dr. Sujuan Ba sits down with Ann Barker, one of the most influential architects of modern cancer research, for a wide-ranging conversation about where the field is headed and what’s standing in the way of real progress. At the heart of the discussion is a simple but uncomfortable truth: cancer research has more data than ever before, but we are not fully equipped to use it.
Listen Now On: Spotify | Apple Podcasts | YouTube | Amazon Music

Episode #14:
FEATURING: Shereen and Isabella Pavlides, Cancer Advocates and NFCR Supporters
Episode 14 of All Things Cancer features Shereen and Isabella Pavlides (co-hosts of Cooking with Shereen and Prevention with Pavlides) discussing how to turn personal loss into action, caregiving perspectives, community impact, and cancer advocacy.
Listen Now On: Spotify | Apple Podcasts | YouTube | Amazon Music

Episode #13:
FEATURING: Dr. Monica Bertagnolli, Former National Institutes of Health (NIH) Director
On Episode 13 of All Things Cancer, Dr. Monica Bertagnolli explores how bold research, emerging technologies, and sustained investment can improve patient outcomes and move cancer science closer to cures for all.










